Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer
This document reports results from an observational study assessing Herceptin (trastuzumab) in patients with HER2-positive advanced gastric …
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach [NA]
A terminated clinical trial evaluating molecularly tailored therapy for metastatic esophageal and gastric cancer; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial
A single-arm exploratory trial evaluating the combination of apatinib and capecitabine as second-line therapy for advanced gastric cancer, w…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: E. Coli Nissle in Oncology [Phase 3]
Phase 3 clinical trial update for Escherichia coli Nissle 1917 in gastric and colorectal cancer; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer [Phase 2]
Phase 2 trial evaluating FOLFOX with or without Ziv-Aflibercept in esophageal and gastric cancer has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers [Phase 2]
Phase 2 clinical trial evaluating tasquinimod in advanced/metastatic hepatocellular, ovarian, renal cell, and gastric cancers has been compl…
-
CLINICAL_TRIALS research · 2018-05-04Clinical Trial Update: Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis [Phase 1]
A Phase 1 clinical trial evaluating intraperitoneal docetaxel in combination with cisplatin and TS-ONE for gastric cancer with peritoneal ca…
-
FDA approval · 2018-04-30FDA Approved: DOCETAXEL — Original Application (Mylan Institutional LLC)
The FDA approved Mylan Institutional LLC's original application for a generic docetaxel anhydrous product (ANDA208859).
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center Study [NA]
This is a multi-center clinical trial evaluating an Enhanced Recovery After Surgery program for gastric cancer; the trial status is listed a…
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: A Study of SC-007 in Subjects With Advanced Cancer [Phase 1]
Phase 1 study of SC-007 in patients with advanced cancer sponsored by AbbVie has been terminated, including colorectal cancer and gastric ca…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer [Phase 2]
A Phase 2 clinical trial of cabazitaxel in previously treated patients with advanced or metastatic gastric cancer has completed.
-
CLINICAL_TRIALS research · 2018-04-18Clinical Trial Update: Web-Mediated Risk Assessment for Endoscopic Screening of Gastric Cancer [NA]
This entry documents a clinical trial evaluating web-mediated risk assessment for endoscopic screening of gastric cancer. The sponsor is the…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301) [Phase 2]
Phase 2 clinical trial AHEAD-301 compares apatinib plus docetaxel with docetaxel alone as second-line therapy for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Screening for Gastric Cancer in High-risk Population
This clinical trial update notes the completion of a study evaluating screening for gastric cancer in individuals at high risk.
-
CLINICAL_TRIALS research · 2018-04-11Clinical Trial Update: The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments
A clinical trial update examining the Immuno-Nutrition Index for patients with advanced gastric cancer undergoing preoperative treatment, fo…
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper Endoscopy [Phase 4]
Phase 4 clinical trial update examining premedication with simethicone alone or with N-acetylcysteine to improve visualization during upper …
-
CLINICAL_TRIALS research · 2018-04-10Clinical Trial Update: Evaluation of the Preventive Effect of Chlorhexidine Acetate Gargle for Upper Gastrointestinal Tract Infection After ESD [NA]
This clinical trial update evaluates whether chlorhexidine acetate gargle can prevent upper gastrointestinal tract infections after endoscop…
-
CLINICAL_TRIALS research · 2018-04-09Clinical Trial Update: Prediction of Benefit From Adjuvant Chemotherapy for pT1N1 Gastric Cancer
An ongoing clinical trial evaluating whether adjuvant chemotherapy provides benefit for patients with pT1N1 gastric cancer; the trial status…
-
CLINICAL_TRIALS research · 2018-04-05Clinical Trial Update: Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701)
A clinical trial update investigating radiomics to predict lymph node metastasis in gastric cancer (RPLNM), sponsored by Nanfang Hospital, S…
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding [Phase 3]
Phase 3 trial evaluating whether proton pump inhibitors can prevent bleeding in gastric cancer patients. The study status is TERMINATED.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Folfiri as Third Line of Treatment
Clinical trial evaluating the FOLFIRI regimen as a third-line treatment for gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies [Phase 2]
A Phase 2 study evaluating ceritinib in ALK- and ROS1-activated gastrointestinal cancers has been terminated.
-
CLINICAL_TRIALS research · 2018-03-29Clinical Trial Update: A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer
This is a completed non-interventional study in Chinese participants with gastric cancer evaluating treatment patterns and clinical outcomes…
-
CLINICAL_TRIALS withdrawal · 2018-03-26Clinical Trial Update: Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer [Phase 3]
A Phase 3 trial evaluating nimotuzumab plus irinotecan as second-line therapy for advanced or recurrent gastric and gastroesophageal junctio…
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites [Phase 3]
Phase 3 clinical trial comparing intraperitoneal paclitaxel plus SOX versus SOX alone in gastric cancer with malignant ascites; current stat…